Grace Therapeutics Inc (GRCE) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Grace Therapeutics, Inc. (GRCE) virtual boshqaruv modeli va tadqiqotlarni tashqi laboratoriyalarga autsorsing qilish orqali xarajatlarni optimallashtiradi. Uzoq muddatli moliyaviy qarz barqarorligi ko'rsatkichi ushbu yondashuvni tasdiqlaydi, bunda so'nggi parametr 0.00 ni tashkil etgan. Barqarorlik Yevropa va AQShdagi kamyob dori vositalari savdosi, shuningdek, pediatrik patologiyalar uchun terapiya usullarini aniqlash bo'yicha ilmiy jamg'armalar bilan hamkorlikdagi sa'y-harakatlar bilan yanada mustahkamlanmoqda.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_GRCE_-_Grace-Therapeutics-Inc._-_Long-Term-Debt-to-Equity-Ratio "GRCE - Grace Tx Uzoq muddatli qarzning kapitalga nisbati 29.10.2024 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Grace Therapeutics Inc (GRCE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Grace Therapeutics, Inc.|GRCE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati Grace Tx|GRCE - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Grace Therapeutics, Inc.|GRCE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Grace Therapeutics|Tezkor likvidlik ko‘rsatkichi gracetx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:gracetx.com - GRCE
Ko'rsatkich bir yildan ortiq muddatli majburiyatlarning kompaniya kapitaliga nisbati sifatida hisoblanadi. Ushbu metrika moliyaviy leveraj darajasini va biznesning tashqi uzoq muddatli moliyalashtirishga bog'liqligini belgilaydi. Hozirda klinik sinovlar bosqichida bo'lgan Grace Therapeutics, Inc. (GRCE) uchun ushbu parametr kelajakdagi kamyob kasalliklar dori vositalariga kiritilgan investitsiyalar xarajatlarini aks ettiradi. Yuqori leveraj faqat kelajakdagi narx belgilash imkoniyati kafolatlangan taqdirda maqbul hisoblanadi. Uzoq muddatli qarzning kapitalga nisbati tendentsiyasini tahlil qilish orqali investor balans strukturasining barqarorligini baholaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|HRMY - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|ceribell.com (CBLL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ACIU|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Tevogen Bio Inc.|alphacognition.com (ACOG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS: Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO - Uzoq muddatli qarzning kapitalga nisbati|ATHE (alteritytherapeutics.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli kreditlarning kapitalga nisbati|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|jupiterneurosciences.com (JUNS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio Inc ANVS|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc AIFF|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti RVPH (revivapharma.com)|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PASG (Passage Bio Corp)|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning o'z kapitaliga nisbati minervaneurosciences.com NERV|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Addex Therapeutics Ltd. (ADXN)|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Cyclerion Therapeutics (CYCN)|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pasithea Therapeutics Corp. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics Inc. (ATXI)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Anew Medical Inc.|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati